CA9 and cancer: Both cell lines are highly metastatic, which allows study of the effectiveness of CAIX/XII inhibitors on localised cancer growth as well as on metastases, the latter only when cancer cells are injected in the mammary fat pad (orthotopic location) or intravenously injected (experimental metastasis).